A one-size-fits-all approach to alternative payment models (APMs) often isn’t very fair to community practices, said Miriam Atkins, MD, FACP, president of the Community Oncology Alliance.
Alternative payment models that treat all practices the same or don’t account for variations aren’t very fair, particularly to community oncology practices, said Miriam Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Atkins was just reelected to a second consecutive term as president.
Transcript
As COA president during the transition from OCM to the EOM, which started July 1, how do you envision leveraging your position to foster collaboration, resilience, and innovation within the community oncology sector?
As the president of COA, I don't think I can really leverage my position for that. The issue with OCM [Oncology Care Model] and EOM [Enhancing Oncology Model], one thing is, my practice was with OCM for a short period of time, and we ended up getting out of it because we had physicians with different tax ID numbers, and that's not qualified [so we had] to get out for that.
But [another] issue is, we had to hire extra staff for the information that [CMS] wanted, and we're already short on staff. So, given the little staff, we had more responsibilities. And the other issue is, we get the MEOS [Monthly Enhanced Oncology Services] payment or a payment, and then [CMS] decides, well, “you didn't meet the criteria, so we're going to take it back.” That's very frustrating, and it doesn't leave us much confidence in how fair this will actually be to community practices.
How can we hope to innovate for the future if at present, practices can’t agree on a suitable alternative payment model to keep community oncology care affordable, reimbursable, and within the community?
One big issue would be to make the reimbursement fair. As long as the hospital can get paid 2 or 3 times more than I can, it's going to make it harder to keep my doors open. The other issue about the payment models is every practice is different, and every state is different. So, it's not one size fits all.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More